HIV Research Trust trustees

Deenan is a UK-based clinical virologist and Professor of Virology at University College London. He is a non-executive Director of North Middlesex University Hospital, and Director of the Wellcome Trust-funded Centre for Health and Population Studies in South Africa. Deenan holds a PhD in Biochemistry as well as medical training. During the Covid-19 pandemic, Deenan served on the Independent Scientific Advisory Group for Emergencies (SAGE).

Anton began caring for people living with HIV in London in 1983. In 1989, he completed his doctorate on tuberculosis (TB)/HIV in Zimbabwe. He is an Honorary Consultant Physician at Chelsea and Westminster Hospital, where he served as Director of the HIV Service from 2008 to 2018, and is an Honorary Professor at the London School of Hygiene and Tropical Medicine. He was President of the International AIDS Society from 2018 to 2020 and served as President of the European AIDS Treatment Network (NEAT-ID) from 2014 to 2024, where he continues as an executive member. He is the Principal Investigator for a Test and Treat project in Tanzania and serves on guideline panels for the European AIDS Clinical Society and the British HIV Association (BHIVA). Anton chairs Data and Safety Monitoring Boards for MRC and PENTA studies and has advised the UK Government Health Select Committee and the Department of Health’s Expert Advisory Group on AIDS. He has published over 450 peer-reviewed papers, primarily focused on the clinical management of HIV and HIV-associated tuberculosis.

Cate is a community medicine specialist and epidemiologist based at McGill University, Canada. Formerly the inaugural Chief Scientific Advisor to UNAIDS and currently a Senior Fellow at the Amsterdam Institute for Global Health and Development, her focus is scientific capacity strengthening and advancing women in global health.

Elizabeth is a research professor based in Kenya who works within the field of global health. Her main areas of research focus on sexually transmitted infections, women’s health, and reproductive health; as well as HIV care, prevention, and treatment. She is Chief Research Officer at the Kenya Medical Research Institute (KEMRI) and led a landmark study on the use of PrEP in Kenya. She holds a Masters and PhD in Public Health.

Euphemia is an epidemiologist based at the Centre for Sexual Health and HIV AIDS Research Zimbabwe, where she is Deputy Executive Director (Science). Her main areas of research include self-care for HIV and sexual and reproductive health, community-led HIV and sexual and reproductive health interventions, including pharmacy-based delivery of HIV pre-and post-exposure prophylaxis. Some of her work focusses on health systems strengthening, and she is a member of the Liverpool School of Tropical Medicine (LSTM) Institute for Resilient Health Systems. Euphemia holds a BPHARM (Hons), from the University of Zimbabwe, MSc Public Health (Health Services Research), from the London School of Hygiene and Tropical Medicine, and a PhD Public Health, from University College London. She is also a National Institute for Health and Care Research Global Health Research Professor.

Faye was Director of Finance for Terrence Higgins Trust until 2021. She now serves on the board of the HIV Research Trust, overseeing proper financial governance. Faye’s experience in both small and large organisations, across not-for-profit and commercial sectors includes financial consultancy, start-up and growth, finance and estates leadership, operations and grants expertise, capital programmes and assets, and technical change management.

Liz is a UK-based epidemiologist who is Professor of Tropical Epidemiology at the London School of Hygiene & Tropical Medicine. Her research investigates the regulation of tuberculosis in HIV prevalent populations and improving access to HIV self-testing.

Richard Angell became Chief Executive of Terrence Higgins Trust in March 2023. Since then, he has played a pivotal role in securing £27 million in government funding for opt-out HIV testing in emergency departments, leading to its expansion across 96 hospitals in England and Scotland. Richard was instrumental in overturning discriminatory blood donation rules affecting gay and bisexual men, as well as people from the UK’s Black communities. He played a key role in securing the UK government’s pledge to end new HIV transmissions by 2030 and was part of the team that helped make Sir Keir Starmer the first UK Prime Minister to publicly take an HIV test.